Select patients for treatment with GAVRETO based on the presence of a RET gene fusion or gene mutation.
The recommended dosage in adults and pediatric patients 12 years and older is 400 mg orally once daily on an empty stomach (no food intake for at least 2 hours before and at least 1 hour after taking GAVRETO).